More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.

Pancreatic cancer kills 50,000 people each year, according to the National Cancer Institute, and there are few effective ...

By Dr. Sanchari Sinha Dutta, Ph.D. New research uncovers how distinct molecular profiles and immune signatures in metastatic ...

Copyright held by the owner/author(s). This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International ...

The SEER database tracks 5-year relative survival rates for pancreatic cancer in the United States, based on how far the cancer has spread. The SEER database, however, does not group cancers by AJCC ...

This discovery opens up new perspectives for the development of targeted therapies. With one of the lowest survival rates, pancreatic cancer urgently requires solutions. The enzyme Mical2, involved in ...

UC San Diego School of Medicine researchers have identified an enzyme called MICAL2 that promotes tumor growth and metastasis in the most common form of pancreatic cancer. Photo by libre de ...

Pancreatic cancer is generally characterized by a poor prognosis. Patients with lung-metastatic pancreatic ductal adenocarcinoma survive longer than those with liver metastases. A study now ...

The Paul-Ehrlich-Institute (PEI) in Germany has granted approval to continue subject enrolment in cohort 5 of Oncolytics ...

From jaundice and uncontrolled blood sugars to cancer concerns, each scenario highlights the importance of patient education ...

Researchers assessed the association of KRAS mutations in metastatic PDAC with the clinical outcomes and responses to first-line chemotherapy regimens.

Actuate Therapeutics has gained orphan medicinal product designation (OMPD) from the European Medicines Agency (EMA) for ...